Silence Therapeutics
SLN
#6719
Rank
NZ$1.41 B
Marketcap
NZ$22.69
Share price
-0.22%
Change (1 day)
162.42%
Change (1 year)

EPS for Silence Therapeutics (SLN)

EPS in 2026 (TTM): NZ-$3.34

According to Silence Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$3.30. In 2025 the company made an earnings per share (EPS) of NZ-$3.20 a decrease over its 2024 EPS that were of NZ-$1.67.

EPS history for Silence Therapeutics from 1996 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$3.344.63%
2025NZ-$3.2090.91%
2024NZ-$1.67-32.65%
2023NZ-$2.49-5.77%
2022NZ-$2.64-13.03%
2021NZ-$3.0310.23%
2020NZ-$2.7558.5%
2019NZ-$1.742.94%
2018NZ-$1.69969.59%
2017NZ-$0.16-79.18%
2016NZ-$0.76-3.11%
2015NZ-$0.78-55%
2014NZ-$1.743.83%
2013NZ-$1.67-84.88%
2012NZ-$11.07134.19%
2011NZ-$4.72-61.8%
2010NZ-$12.37-45.65%
2009NZ-$22.76-1.16%
2008NZ-$23.034.29%
2007NZ-$22.0810.54%
2006NZ-$19.97-22.29%
2005NZ-$25.70-57.32%
2004NZ-$60.2239.1%
2003NZ-$43.2970.67%
2002NZ-$25.37-25.17%
2001NZ-$33.905.29%
2000NZ-$32.20-24.54%
1999NZ-$42.6726.7%
1998NZ-$33.68-11.73%
1997NZ-$38.1572.24%
1996NZ-$22.15